dwadlogopng Facebook circle black small Google + circle black small Twitter circle black small
RSS Feed

Web feed


Check back regularly to keep up to date with our latest news

Facebook circle blue small Twitter circle blue small

Her Majesty’s Revue and Customs (HMRC) have examined our business plan and cash flow forecasts of Drugs With A Difference Limited and given the company advanced assurance under their Enterprise Invest Scheme (EIS) to raise £3.45 million.


Any shares bought under this scheme have significant tax advantages and profits from shares kept for 3 years from the date of issue become net of (1) Income tax and (2) Capital Gains Tax.


We have recently filed 5 patent applications at the UK Intellectual Property Office (UKIPO) for drugs to treat breast cancer, colorectal cancer, prostate cancer, lung cancer and brain cancer.